MASS
908 DEVICES (MASS)
NASDAQ
$8.66-$0.20 (-2.20%)
Price as of Jun 03, 2026 4:15 PM EDT
  • $318.0M
    Market Cap
  • 33.69%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 63
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

908 Devices (MASS) Q2 Revenue Jumps 14%

908 Devices reported Q2 2025 revenue of $13.0 million, a 14% year-over-year increase, but experienced margin pressures and widened net losses. The company continues strategic investments and restructuring while targeting EBITDA break-even in Q4 2025.

08/05/2025, 10:31 PM • The Motley Fool

Peers

Statistics

More
Day Range
$8.55
$8.95
$8.85
1-Year Range
$5.09
$9.15
$8.85
Latest Close$8.85
Change
+$0.22 (+2.49%)
Volume301,709
Market Cap$318.0M
Shares Outstanding37.8M
P/E (TTM)-8.45
Diluted EPS (TTM)-$0.99
Enterprise Value$250.4M

Information as of 06/02/2026

Company Profile

908 DEVICES INC
908 DEVICES INC
https://908devices.com
$318.0M
Market Cap
-$36.1M
Net Income
Sector: Healthcare
Industry: Medical Devices
44 3rd Avenue, Burlington, MA, United States, 01803
857 254 1500

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Key Executives

  • Kevin J. Knopp
  • Joseph H. Griffith
  • John Kenneweg
  • Christopher David Brown
  • Mark S. Levine

Current Ownership Distribution

  • Institutions387.9M (71.09%)
  • Mutual Funds144.4M (26.47%)
  • Insiders13.3M (2.44%)
  • Other0 (0.00%)